, Volume 107, Issue 1, pp 61–68 | Cite as

Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action

  • A. Fernández-Guasti
  • E. Hong
  • C. López-Rubalcava
Original Investigations


The effect of three anxiolytic drugs, indorenate, ipsapirone and diazepam, on the burying behaviour of rats and mice was studied. All three drugs induced a reduction in burying behaviour interpreted as a reduction in anxiety. However, a species difference in the diazepam sensitivity was found: rats showed a clear effect after 1.0 mg/kg while already at 0.25 mg/kg an action was observed in mice. The serotonergic anxiolytics produced similar responses at similar doses (2.5–5.0 mg/kg) in both species. The serotonergic antagonists, pindolol (3.1 mg/kg), alprenolol (5.0 mg/kg) and methiotepin (0.31 mg/kg), induced a slight reduction in the time spent burying but effectively counteracted the anxiolytic action of the serotonergic agonists in mice but not in rats. By contrast, in rats, the beta blocker, practolol (0.5 mg/kg), was the only drug effective in preventing the anxiolytic actions of ipsapirone. The combined treatment of indorenate and methiotepin resulted in an impairment of motor coordination and ambulatory behaviour in both species studied, thereby suggesting that the lack of effect of such combination was mediated by altering the motor behaviour. Finally, the reduction in ambulatory behaviour in mice produced by ipsapirone was effectively prevented by the antagonists methiotepin, pindolol and alprenolol indicating the involvement of a serotonergic receptor in this effect. From these results it is concluded that a different mechanism underlies the anxiolytic actions of indorenate and ipsapirone in mice and rats.

Key words

Indorenate Ipsapirone Diazepam Beta-blockers 5-HT1 antagonists Burying behaviour 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahlenius S, Larsson K (1987) Evidence for a unique pharmacological profile of 8-OH-DPAT by evaluation of its effects on male rat sexual behaviour. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 185–198Google Scholar
  2. Amrick CL, Bennett DA (1986) A comparison of the anticonflict activity of serotonin agonists and antagonists in rats. Soc Neurosci Abstr 12:907Google Scholar
  3. Barrett JE, Witkin JM, Mansbach RS, Skolnick P, Weissman BA (1986) Behavioural studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanism. J Pharmacol Exp Ther 238:1009–1013Google Scholar
  4. Benitez-King G, Antón-Tay F, Hong E (1991) Characterization of indorenate effects on brain monoamine metabolism. Drug Dev Res 34:433–437Google Scholar
  5. Broekkamp CLE, Berendsen HHG, Jenk F, Van Delft AML (1989) Animal models for anxiety and response to serotonergic drugs. Psychopathology 22 [suppl 1]:2–12Google Scholar
  6. Craft RM, Howard JL, Pollard GT (1988) Conditioned defensive burying as a model for identifying anxiolytics. Pharmacol Biochem Behav 30:775–780Google Scholar
  7. Critchley MAE, Handley SL (1987) Effects in the X maze anxiety model of agents acting at the 5-HT1 and 5-HT2 receptors. Psychopharmacology 93:502–506Google Scholar
  8. Dompert WV, Glaser T, Traber J (1985) 3H-TVX Q 7821: identification of 5-HT1 binding sites as a target for a novel putative anxiolytic. Naunyn Schmiedeberg's Arch Pharmacol 328:467–470Google Scholar
  9. Dourish CT (1987) Brain 5-HT receptors and anxiety. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 261–277Google Scholar
  10. Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms in the behavioural effects of buspirone and gepirone. Pharmacol Biochem Behav 24:701–707Google Scholar
  11. Engel JA, Hjorth S, Svensson K, Carlsson A, Lilieqvist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368Google Scholar
  12. Fernández-Guasti A, Hong E (1989) Antianxiety effect of various putative S1 receptor agonists on the conditioned defensive burying paradigm. In: Bevan P, Cools AR, Archer T (eds) The behavioural pharmacology of 5-HT. Lawrence Earlbaum, New York, pp 377–382Google Scholar
  13. Fernández-Guasti A, López-Rubalcava C (1990) Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone. Psychopharmacology 101:354–358Google Scholar
  14. Fernández-Guasti A, Picazo O (1990) The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase. Pharmacol Biochem Behav 37:77–81Google Scholar
  15. Fernández-Guasti A, Escalante A, Hong E, Agmo A (1990) Behavioural actions of indorenate, a new putative 5-HT1A agonist. Pharmacol Biochem Behav 37:83–88Google Scholar
  16. File S (1985) Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour. Neuropsychobiology 13:55–62Google Scholar
  17. File S, Johnston AL, Pellow S (1987) Effects of compounds acting at CNS 5-hydroxytryptamine systems on anxiety in the rat. Br J Pharmacol 90:265PGoogle Scholar
  18. Gardner CR (1985) Pharmacological studies of the role of serotonin in animal models of anxiety. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, New York, pp 281–325Google Scholar
  19. Geller I, Hartmann RJ (1982) Effects of buspirone on operant behaviour of laboratory rats and cynomologous monkeys. J Clin Psychiatry 43:25–32Google Scholar
  20. Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743–753Google Scholar
  21. Goodwin GM, De Souza RJ, Green AR (1986) The effects of a 5-HT1 receptor ligand ipsapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Psychopharmacology 89:382–387Google Scholar
  22. Green AR, Goodwin GM (1987) The pharmacology of the hypothermic response of rodents to 8-OH-DPAT administration and the effects of psychotropic drug administration on this response. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 161–176Google Scholar
  23. Hjorth S (1985) Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT. J Neural Transm 61:131–135Google Scholar
  24. Hong E, Villalón C (1988) External carotid vasodilation induced by serotonin and indorenate. Proc West Pharmacol Soc 31:99Google Scholar
  25. Hoyer D, Engel G, Kalman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with (3H) 5-HT, (3H) 8-OH-DPAT, (-) (125I) Iodocyanopindolol, (3H) mesulergine and (3H) ketanserin. Eur J Pharmacol 118:13–23Google Scholar
  26. Hutson PH, Dourish CT, Curzon G (1987) 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT)-induced hyperphagia: neurochemical and pharmacological evidence for an involvement of 5-hydroxytryptamine somatodendritic receptors. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 209–232Google Scholar
  27. Hutson PH, Dourish CT, Curzon G (1988) Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol 150:361–366Google Scholar
  28. Kelly D (1980) Clinical review of beta-blockers in anxiety. Pharmacopsychiatry 13:259–274Google Scholar
  29. Korte SM, Bohus B (1990) The effect of ipsapirone on behavioural and cardiac responses in the shock-probe/defensive burying test in male rats. Eur J Pharmacol 181:307–310Google Scholar
  30. Lloyd KD, Bartholini G (1974) The effect of methiotepin on cerebral monoamine neurons. In: Costa E, Gessa GL, Sandler M (eds) Advances in biochemical psychopharmacology, vol 10. Serotonin: new vistas. Raven Press, New York, pp 305–309Google Scholar
  31. Maggio JC, Harder DB (1983) Genotype and environment interactively determine the magnitude, directionality, and abolition of defensive burying in mice. Anim Learn Behav 11:162–172Google Scholar
  32. Morselli PL, Kilborn JR, Cavero I, Harrison DC, Langer SZ (1983) Betaxolol and other β1-adrenoceptor antagonists. Raven Press, New YorkGoogle Scholar
  33. Njung'e K, Handley SL (1991) Evaluation of marble-burying behaviour as a model of anxiety. Pharmacol Biochem Behav 38:63–67Google Scholar
  34. Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39:917–928Google Scholar
  35. Pinel JPJ, Treit D (1978) Burying as a defensive response in rats. J Comp Physiol Psychol 92:708–712Google Scholar
  36. Rohmer JG, Di Scala G, Sandner G (1990) Behavioural analysis of the effects of benzodiazepine receptor ligands in the conditioned burying paradigm. Behav Brain Res 38:45–54Google Scholar
  37. Sanger DJ, Joly D, Zivkovik B (1985) Behavioural effects of non-benzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide. J Pharmacol Exp Ther 232:831–837Google Scholar
  38. Shepherd JK, Rodgers RJ (1990) 8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition. Psychopharmacology 101:408–413Google Scholar
  39. Siegel S (1956) Non parametric statistics for the behavioral sciences. McGraw-Hill, New YorkGoogle Scholar
  40. Svensson K, Larsson K, Ahlenius S, Arvidsson L-E, Carlsson A (1987) Evidence for a facilitatory role of central 5-HT in male mouse sexual behaviour. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology. Ellis Horwood, Chichester, pp 199–210Google Scholar
  41. Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidel PR (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12:741–744Google Scholar
  42. Treit D (1985) Animal models for the study of antianxiety agents: a review. Neurosci Biobehav Rev 9:203–222Google Scholar
  43. Treit D, Fundytus M (1988) A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics. Pharmacol Biochem Behav 30:1071–1075Google Scholar
  44. Treit D, Pinel JPJ, Fibiger HC (1981) Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15:619–626Google Scholar
  45. Witkin JM, Barrett JE (1986) Interaction of buspirone and dopaminergic agents on punished behaviour in pigeons. Pharmacol Biochem Behav 24:751–756Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • A. Fernández-Guasti
    • 1
    • 2
  • E. Hong
    • 1
    • 2
  • C. López-Rubalcava
    • 1
    • 2
  1. 1.Sección de Terapéutica Experimental, Departamento de Farmacología y ToxicologíaCINVESTAVMéxico D.F.México
  2. 2.División de Investigaciones en NeurocienciasInstituto Mexicano de PsiquiatríaMéxico D.F.México

Personalised recommendations